EICHOR
● Active Not Recruiting
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
Condition: Non-Small Cell Lung Cancer · Sponsor: Hoffmann-La Roche
About this study
This is a Phase III, global, multicenter, open-label, randomized study to compare the efficacy and safety of 16 cycles (1 cycle duration=21 days) of atezolizumab (MPDL3280A) treatment compared with best supportive care (BSC) in participants with Stage IB-Stage IIIA non-small cell lung cancer (NSCLC) following resection and adjuvant chemotherapy, as measured by disease-free survival (DFS) as assessed by the investigator and overall survival (OS). Participants, after completing up to 4 cycles of adjuvant cisplatin-based chemotherapy, will be randomized in a 1:1 ratio to receive atezolizumab for 16 cycles or BSC.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (155)
| Highlands Oncology Group | Fayetteville, Arkansas, United States | — |
| California Cancer Associates for Research & Excellence, Inc. | Encinitas, California, United States | — |
| Compassionate Cancer Care Medical Group, Inc | Fountain Valley, California, United States | — |
| University of California Los Angeles | Los Angeles, California, United States | — |
| Kaiser Permanente | Vallejo, California, United States | — |
| Kaiser Permanente - Walnut Creek | Walnut Creek, California, United States | — |
| Eastern Connecticut Hematology and Oncology Associates | Norwich, Connecticut, United States | — |
| Lynn Cancer Institute - West | Boca Raton, Florida, United States | — |
| University of Miami School of Medicine - Sylvester at Deerfield | Deerfield Beach, Florida, United States | — |
| SCRI Florida Cancer Specialists North | St. Petersburg, Florida, United States | — |
| Lewis Hall Singletary Oncology Center | Thomasville, Georgia, United States | — |
| University of Illinois at Chicago | Chicago, Illinois, United States | — |
+ 143 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT02486718